Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch (Q40073524)

17 September 2017

Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch (English)

1 reference

17 September 2017

0 references

Orthoebolavirus zairense

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Hung-Wei Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ling Ye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xin Dong Guo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Chinglai Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Richard W Compans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

7 November 2016

1 reference

Advanced Healthcare Materials

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Ebola vaccine--an urgent international priority

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

DNA vaccines: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

The future of cell culture-based influenza vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Developments in Viral Vector-Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

DNA vaccination in the skin using microneedles improves protection against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Polymer multilayer tattooing for enhanced DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

In vivo function of Langerhans cells and dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Microneedle patches for vaccination in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Targeting the skin for microneedle delivery of influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Microneedles for drug and vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Current advances in the fabrication of microneedles for transdermal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

Human Growth Hormone Delivery with a Microneedle Transdermal System: Preclinical Formulation, Stability, Delivery and PK of Therapeutically Relevant Doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201600750

21 January 2018

Identifiers

DOI

10.1002/ADHM.201600750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28075069%20AND%20SRC:MED&resulttype=core&format=json

release_ljhjbs7gbneotal3qtkkfn74x4

9 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ljhjbs7gbneotal3qtkkfn74x4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference